IONIS-FXIRX

N/A

Report date: 2025/10/20 14:43:45
NME

Base Information

Drug NameIONIS-FXIRX
Drug Alias NameFactor XI antisense oligonucleotideIONIS FXIRxISIS-404071IONIS-FXIRXBAY-2306001 +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCoagulation factor XI inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsThrombosisVenous Thromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncBayer AG
Inactive CompaniesN/A
Active IndicationsThrombosisVenous Thromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A